Ono Pharmaceutical Co., Ltd.

4528.T · JPX
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Assets
Cash & Equivalents¥204,567¥166,141¥96,135¥69,112
Short-Term Investments¥5,813¥38,454¥68,154¥47,857
Receivables¥135,022¥136,066¥114,396¥99,788
Inventory¥74,864¥48,629¥44,814¥41,817
Other Curr. Assets¥34,838¥9,607¥7,861¥11,740
Total Curr. Assets¥455,104¥413,596¥345,101¥281,266
Property Plant & Equip (Net)¥105,721¥104,752¥108,420¥112,131
Goodwill¥21,186¥0¥0¥0
Intangibles¥330,041¥57,288¥69,134¥64,734
Long-Term Investments¥96,502¥297,170¥252,710¥252,456
Tax Assets¥51,020¥0¥35,604¥25,074
Other NC Assets¥4,472¥40,862¥71,468¥3,542
Total NC Assets¥608,942¥500,072¥537,336¥457,937
Other Assets¥0¥0¥0¥0
Total Assets¥1,064,046¥913,668¥882,437¥739,203
Liabilities
Payables¥89,329¥60,691¥66,794¥49,689
Short-Term Debt¥30,000¥2,310¥2,490¥2,301
Tax Payable¥4,058¥22,093¥34,575¥1,526
Deferred Revenue¥0¥22,093¥35,236¥2,242
Other Curr. Liab.¥21,731-¥19,366-¥30,382-¥1,466
Total Curr. Liab.¥148,296¥103,624¥122,929¥65,926
LT Debt¥105,000¥0¥0¥0
Deferred Rev, NC¥0¥0¥0¥0
Deferred Tax Liab, NC¥10,817¥1,013¥983¥1,009
Other NC Liab.¥3,231¥3,874¥4,034¥4,093
Total NC Liab.¥127,548¥11,439¥11,695¥11,603
Other Liabilities¥0¥0¥0¥0
Cap. Leases¥11,678¥8,862¥9,168¥8,802
Total Liabilities¥275,844¥115,063¥134,624¥77,529
Equity
Pref Stock¥0¥0¥0¥0
Common Stock¥17,358¥17,358¥17,358¥17,358
Retained Earnings¥790,908¥768,183¥709,890¥644,754
AOCI¥19,790¥53,195¥51,702¥51,236
Other Equity¥0¥0¥0¥0
Total Equity¥782,451¥792,961¥741,869¥655,906
Supplemental Information
Minority Interest¥5,751¥5,644¥5,944¥5,768
Total Liab. & Tot. Equity¥1,064,046¥913,668¥882,437¥739,203
Net Debt-¥69,567-¥163,831-¥93,645-¥66,811
Ono Pharmaceutical Co., Ltd. (4528.T) Financial Statements & Key Stats | AlphaPilot